Review article: dual delayed release formulation of dexlansoprazole MR, a novel approach to overcome the limitations of conventional single release proton pump inhibitor therapy.

作者: D. C. METZ , M. VAKILY , T. DIXIT , D. MULFORD

DOI: 10.1111/J.1365-2036.2009.03984.X

关键词: DrugPharmacodynamicsLansoprazolePharmacologyMedicineDosingDrug deliveryDosage formDexlansoprazolePharmacokinetics

摘要: … To maintain prolonged plasma concentrations, dexlansoprazole MR releases drug over a longer period than conventional delayed release PPIs and thereby requires higher daily doses…

参考文章(45)
D O Castell, B Kuo, Optimal dosing of omeprazole 40 mg daily: effects on gastric and esophageal pH and serum gastrin in healthy controls. The American Journal of Gastroenterology. ,vol. 91, pp. 1532- 1538 ,(1996)
David J. Hetzel, John Dent, William D. Reed, Firoze M. Narielvala, M. Mackinnon, Justin H. McCarthy, Brent Mitchell, Bruce R. Beveridge, Bernard H. Laurence, Geoffrey G. Gibson, Alan Kerr Grant, David J.C. Shearman, Richard Whitehead, Peter J. Buckle, Healing and relapse of severe peptic esophagitis after treatment with omeprazole Gastroenterology. ,vol. 95, pp. 903- 912 ,(1988) , 10.1016/0016-5085(88)90162-X
Hisakazu Katsuki, Hatsumi Yagi, Kazuhiko Arimori, Chizuko Nakamura, Masahiro Nakano, Shigeru Katafuchi, Yuhichi Fujioka, Shigetoshi Fujiyama, Determination of R(+)- and S(-)-lansoprazole using chiral stationary-phase liquid chromatography and their enantioselective pharmacokinetics in humans Pharmaceutical Research. ,vol. 13, pp. 611- 615 ,(1996) , 10.1023/A:1016062508580
Lind, Rydberg, Kylebäck, Jonsson, Andersson, Hasselgren, Holmberg, Röhss, Esomeprazole provides improved acid control vs. omeprazole In patients with symptoms of gastro-oesophageal reflux disease. Alimentary Pharmacology & Therapeutics. ,vol. 14, pp. 861- 867 ,(2000) , 10.1046/J.1365-2036.2000.00813.X
Anke Richter, Susan E. Anton, Peter Koch, Susan L. Dennett, The impact of reducing dose frequency on health outcomes Clinical Therapeutics. ,vol. 25, pp. 2307- 2335 ,(2003) , 10.1016/S0149-2918(03)80222-9
Ami J. Claxton, Joyce Cramer, Courtney Pierce, A systematic review of the associations between dose regimens and medication compliance Clinical Therapeutics. ,vol. 23, pp. 1296- 1310 ,(2001) , 10.1016/S0149-2918(01)80109-0
B.R. Yacyshyn, A.B.R. Thomson, The clinical importance of proton pump inhibitor pharmacokinetics. Digestion. ,vol. 66, pp. 67- 78 ,(2002) , 10.1159/000065588
J. MASON, A. P. S. HUNGIN, Review article: gastro-oesophageal reflux disease--the health economic implications. Alimentary Pharmacology & Therapeutics. ,vol. 22, pp. 20- 31 ,(2005) , 10.1111/J.1365-2036.2005.02606.X
F. Boileau, D.Y. Kim, K.D. Cho, G.J. Chung, R. Goldwater, S.M. Lee, Phase 1, randomized, parallel, placebo‐controlled, safety, tolerance and pharmacokinetic study of multiple dose of IY‐81149 in fasting male volunteers Clinical Pharmacology & Therapeutics. ,vol. 65, pp. 126- 126 ,(1999) , 10.1016/S0009-9236(99)80034-4B